Results 81 - 90 of 1589 : Previous 5 6 7 8 9 10 11 12 13 Next
Taking the Drug Industry's Temperature
Covance and Icon hint at broader pharmaceutical R&D trends.
Swine Flu Doesn't Need to Save Novartis
The company is looking healthy all on its own.
It's their loss.
Not 50% Growth, but We'll Take It
Double-digit growth is still pretty good.
Elan's Headed in the Right Direction
Almost in the black.
Beat Earnings, Stock Down, Rinse and Repeat
Not a good trend.
Nibbles Here and There at Forest Labs
Forest Laboratories banks on its usual strategy to offset generic-drug threats.
Manufacturing problems knock down Genzyme.
Another delay for Prolia.
Double-Digit Growth in a Recession
Virus-killing Gilead gets it done.
Results 81 - 90 of 1589 : Previous 5 6 7 8 9 10 11 12 13 Next